期刊文献+

乳腺癌180例临床病理分析 被引量:2

Clinical Pathological Analysis of 180 Cases of Breast Cancer
暂未订购
导出
摘要 目的:对乳腺癌的临床特点及病理特征进行分析。方法:对2012年1月~2017年1月某院收治的180例病理确诊的乳腺癌患者临床资料,总结本组患者的临床特点,剖析病理表现。结果:本组180例患者均为女性,发病年龄(49.5±3.4)岁;首发症状是乳腺肿块,病理确诊时间为(10.5±1.8)个月;肿瘤直径(3.10±0.14)cm;主要是浸润性导管癌,占比90.6%,转移率达到58.5%,以同侧腋下淋巴结转移为主;雌激素受体(ER)阳性率为45.5%,孕激素受体(PR)阳性率为44.4%,人表皮生长因子受体2(Cerb-B-2)阳性率为81.4%,且Cerb-B-2蛋白表达和ER、PR表达相关。结论:乳腺癌以中老年女性为主要发病群,早期诊断率不高,绝大多数就诊时是浸润癌,且部分已转移,所以要早发现、早诊疗。 Objective:To analyze the clinical and pathological characteristics of breast cancer.Methods:The clinical data of 180 patients with pathologically confirmed breast cancer treated in a hospital from January2012 to January 2017 were analyzed.Results:180 patients were female,the age of onset was(49.5±3.4);The first symptom was breast mass,the time of pathological diagnosis was(10.5±1.8)months,the diameter of tumor was(3.10±0.14)cm;It was mainly invasive ductal carcinoma,accounting for 90.6%,and the metastasis rate was 58.5%,mainly ipsilateral axillary lymph node metastasis;The positive rate of ER and PR was 45.5% and 44.4%,respectively.The positive rate of human epidermal growth factor receptor 2 Cerb-B-2 was 81.4%,and the expression of Cerb-B-2 protein was correlated with the expression of ERP and PR.Conclusion:Breast cancer mainly occurs in middle-aged and elderly women,the early diagnosis rate is not high,the vast majority of patients are invasive cancer,and part of the metastasis,so it should be found,diagnosed,and treated early.
出处 《数理医药学杂志》 2018年第2期167-169,共3页 Journal of Mathematical Medicine
关键词 乳腺癌 病理学分析 临床诊断 breast cancer pathological analysis clinical diagnosis
  • 相关文献

参考文献4

二级参考文献36

  • 1中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2007版)[J].中国癌症杂志,2007,17(5):410-428. 被引量:243
  • 2Perou CM,Sorlie T,Eisen MB,et al.Molecular portraits of human breast tumors[J].Nature,2000,406:747-752.
  • 3Jacquemier J,Ginestier C,Rougemont J,et al.Protein expression profiling identifies subclasses of breast cancer and predicts prognosis[J].Cancer Res,2005,65:767-779.
  • 4Jacquemier J,Padovani L,Rabayrol L,et al.Typical medullar breast carcinomas have abasal/myoep it helial phenotype[J].Pathol,2005,207:260-268.
  • 5Dent R,Trudeau M,Pritchard KI,et al.Triple-negative breast cancer:clinical features and patterns of recurrence[J].Clin Cancer Res,2007,13:4429-4434.
  • 6Haffty BG,Yang Q,Reiss M,et al.Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer[J].J Clin Oncol,2006,24:5652-5657.
  • 7Tischkowitz M,Brunet JS,Begin LR,et al.Use of immunohistochemical markes can refine prognosis in triple negative breast cancer[J].BMC Cancer,2007,7:134.
  • 8Rakha EA,EISayed ME,Green AR,et al.Prognostic markers in triple-negative breast cancer[J].Cancer,2007,109:25-32.
  • 9Foulkes WD,Metcalfe K,Hanna W,et al.Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCAl-related breast carcinoma[J].Cancer,2003,98:1569-1577.
  • 10Rakha EA,EI-Sayed ME,Green AR,et al.Prognostic markers in triple-negative breast cancer[J].Cancer,2007,109:25-32.

共引文献40

同被引文献19

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部